BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND AXIN2, AXIL, 8313, ENSG00000168646, MGC126582, DKFZp781B0869
25 results:

  • 1. prostate-Specific Membrane Antigen (PSMA) Expression Predicts Need for Early Treatment in prostate cancer Patients Managed with Active Surveillance.
    Ahmadi E; Wang S; Gouran-Savadkoohi M; Douvi G; Isfahanian N; Tsakiridis N; Faught BE; Cutz JC; Sur M; Chawla S; Pond GR; Steinberg GR; Brown I; Tsakiridis T
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003213
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. cancer-derived exosomal miR-375 targets DIP2C and promotes osteoblastic metastasis and prostate cancer progression by regulating the Wnt signaling pathway.
    Liu Y; Yang C; Chen S; Liu W; Liang J; He S; Hui J
    Cancer Gene Ther; 2023 Mar; 30(3):437-449. PubMed ID: 36434177
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Integration of Automatic Text Mining and Genomic and Proteomic Analysis to Unravel prostate cancer Biomarkers.
    Lima T; Ferreira R; Freitas M; Henrique R; Vitorino R; Fardilha M
    J Proteome Res; 2022 Feb; 21(2):447-458. PubMed ID: 35114790
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal cancer.
    Rajamäki K; Taira A; Katainen R; Välimäki N; Kuosmanen A; Plaketti RM; Seppälä TT; Ahtiainen M; Wirta EV; Vartiainen E; Sulo P; Ravantti J; Lehtipuro S; Granberg KJ; Nykter M; Tanskanen T; Ristimäki A; Koskensalo S; Renkonen-Sinisalo L; Lepistö A; Böhm J; Taipale J; Mecklin JP; Aavikko M; Palin K; Aaltonen LA
    Gastroenterology; 2021 Aug; 161(2):592-607. PubMed ID: 33930428
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Are developmentally missing teeth a predictive risk marker of malignant diseases in non-syndromic individuals? A systematic review.
    Al-Muzian L; Almuzian M; Mohammed H; Ulhaq A; Keightley AJ
    J Orthod; 2021 Sep; 48(3):221-230. PubMed ID: 33455496
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Design, synthesis, and antitumor activity of novel compounds based on 1,2,4-triazolophthalazine scaffold: Apoptosis-inductive and PCAF-inhibitory effects.
    Turky A; Bayoumi AH; Ghiaty A; El-Azab AS; A-M Abdel-Aziz A; Abulkhair HS
    Bioorg Chem; 2020 Aug; 101():104019. PubMed ID: 32615465
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The association between three axin2 variants and cancer risk.
    Dai F; Zhu LJ; Zhang W; Mi YY; Sun HY; Zhang LF; Yue C; Wu XY; Zuo L; Bai Y
    J Cell Biochem; 2019 Sep; 120(9):15561-15571. PubMed ID: 31038806
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Effects of diabetes mellitus and Metformin administration on prostate cancer detection at biopsy among Chinese men: a case-control study.
    Hu MB; Bai PD; Wu YS; Zhang LM; Zhu WH; Hu JM; Yang T; Jiang HW; Ding Q
    J BUON; 2019; 24(1):227-232. PubMed ID: 30941974
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. TMEPAI/PMEPA1 inhibits Wnt signaling by regulating β-catenin stability and nuclear accumulation in triple negative breast cancer cells.
    Amalia R; Abdelaziz M; Puteri MU; Hwang J; Anwar F; Watanabe Y; Kato M
    Cell Signal; 2019 Jul; 59():24-33. PubMed ID: 30890370
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
    Katoh M
    Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MEIS1 and MEIS2 Expression and prostate cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease.
    Bhanvadia RR; VanOpstall C; Brechka H; Barashi NS; Gillard M; McAuley EM; Vasquez JM; Paner G; Chan WC; Andrade J; De Marzo AM; Han M; Szmulewitz RZ; Vander Griend DJ
    Clin Cancer Res; 2018 Aug; 24(15):3668-3680. PubMed ID: 29716922
    [No Abstract]    [Full Text] [Related]  

  • 12. An Indispensable Role of Androgen Receptor in Wnt Responsive Cells During prostate Development, Maturation, and Regeneration.
    He Y; Hooker E; Yu EJ; Wu H; Cunha GR; Sun Z
    Stem Cells; 2018 Jun; 36(6):891-902. PubMed ID: 29451339
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Mutations in axin2 gene as a risk factor for tooth agenesis and cancer: A review.
    Hlouskova A; Bielik P; Bonczek O; Balcar VJ; Šerý O
    Neuro Endocrinol Lett; 2017 Jul; 38(3):131-137. PubMed ID: 28759178
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. New concept of the axin2 rs2240308 polymorphism and cancer risk: an updated meta-analysis.
    Yu Y; Tao Y; Liu L; Yang J; Wang L; Li X; Zhuang X; Chu M
    Neoplasma; 2017; 64(2):269-277. PubMed ID: 28043155
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. axin2 expression predicts prostate cancer recurrence and regulates invasion and tumor growth.
    Hu BR; Fairey AS; Madhav A; Yang D; Li M; Groshen S; Stephens C; Kim PH; Virk N; Wang L; Martin SE; Erho N; Davicioni E; Jenkins RB; Den RB; Xu T; Xu Y; Gill IS; Quinn DI; Goldkorn A
    Prostate; 2016 May; 76(6):597-608. PubMed ID: 26771938
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cotargeting Polo-Like Kinase 1 and the Wnt/β-Catenin Signaling Pathway in Castration-Resistant prostate cancer.
    Li J; Karki A; Hodges KB; Ahmad N; Zoubeidi A; Strebhardt K; Ratliff TL; Konieczny SF; Liu X
    Mol Cell Biol; 2015 Dec; 35(24):4185-98. PubMed ID: 26438599
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Five-year downstream outcomes following prostate-specific antigen screening in older men.
    Walter LC; Fung KZ; Kirby KA; Shi Y; Espaldon R; O'Brien S; Freedland SJ; Powell AA; Hoffman RM
    JAMA Intern Med; 2013 May; 173(10):866-73. PubMed ID: 23588999
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Tooth agenesis association with self-reported family history of cancer.
    Küchler EC; Lips A; Tannure PN; Ho B; Costa MC; Granjeiro JM; Vieira AR
    J Dent Res; 2013 Feb; 92(2):149-55. PubMed ID: 23169889
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Small molecule-based promotion of PKCα-mediated β-catenin degradation suppresses the proliferation of CRT-positive cancer cells.
    Gwak J; Lee JH; Chung YH; Song GY; Oh S
    PLoS One; 2012; 7(10):e46697. PubMed ID: 23071615
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.
    Yang GB; Barnholtz-Sloan JS; Chen Y; Bordeaux JS
    Arch Dermatol; 2011 Dec; 147(12):1395-402. PubMed ID: 22184761
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.